Silicone breast implant manufacturer GC Aesthetics Ltd has launched a minimal-touch implant insertion device, HydroCone, which will be released in the UK later this year.
Midlands cosmetic surgeon Dalvi Humzah is calling on the Government to reinstate The National Breast Implant Registry (UKBIR).
We find out how the Venus Freeze painlessly achieves significant rejuvenation and body shaping results.
The Times newspaper has named Professor Simon Kay, consultant plastic and reconstructive surgeon at Spire Leeds Hospital and Leeds Teaching Hospitals NHS Trust, as one of ‘Britain’s Top Doctors’. Published in a special edition of The Times Magazine, the guide to the elite of Britain’s doctors was compiled in conjunction with professional bodies and associations, specialists and charities, who listed candidates considered to be leaders in their medical fields, based not just on academic brilliance but also personal qualities such as dedication, empathy and drive.
Test results issued from the French Competent Authority (AFSSAPS) into controversial PIP breast implants cannot entirely rule out genotoxicity (DNA cell disruption) a report has shown.
The British Association of Aesthetic Plastic Surgeons has welcomed the Government’s review into the PIP scandal and agrees with its recommendations that more stringent criteria should be required into monitoring medical devices. The BAAPS has also reiterated its previous calls for a compulsory implant register, mandatory safety audits for all practitioners and mystery shopping-type surveillance.
Cosmetic surgery group Surgicare has been sold after falling into administration. Joint administrators Chris Ratten and Jeremy Woodside at RSM Tenon, who were appointed to the business on October 29, said the firm was hit by a fall in trade.The business has been acquired for an undisclosed sum by The Hospital Medical Group, based in Bromsgrove, through a new vehicle, RAM1001. The deal has saved 37 jobs at Surgicare.
The Food and Drug Administration (FDA) has announced a public warning of unapproved versions of Juvéderm.
The British Association of Aesthetic Plastic Surgeons (BAAPS) has advised its members to refrain from performing buttock augmentation through fat transfer until more proven data is released.
The US Food and Drug Administration (FDA) has changed the microneedling device classification for aesthetic use to a class II, rather than the automatic class III assignment.